Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA "Drug Watch" Listing Removal Criteria Need Greater Clarity - PhRMA

Executive Summary

FDA's criteria for removing a product from the proposed "Drug Watch" website are subjective and will make it difficult, if not impossible, for a drug to be taken off the list, the Pharmaceutical Research & Manufacturers of America said

You may also be interested in...



FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch

Despite FDA's decision to drop its proposed "Drug Watch" Web site, the agency will continue to make emerging drug safety information available to the public

FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch

Despite FDA's decision to drop its proposed "Drug Watch" Web site, the agency will continue to make emerging drug safety information available to the public

FDA Stays Positive On Rx Safety Info Sheets, But Drug Watch Still In Question

Drug information sheets published by FDA in 2005 demonstrate the agency's focus on important safety issues, Drug Safety Oversight Board Executive Director Susan Cummins said Jan. 23 at a Drug Information Association conference in Washington, D.C

Related Content

Topics

UsernamePublicRestriction

Register

PS046196

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel